WFH NETWORK

WFH Notice: recall of desmopressin nasal spray by Ferring Pharmaceuticals

July 20, 2020

The WFH has learned of a voluntary product recall of desmopressin nasal spray by Ferring Pharmaceuticals, due to out of specification results of the active ingredient. As of mid-July 2020, affected batches of these products have been recalled in a number of countries as a precautionary measure. Patients are advised to contact their healthcare provider or pharmacist to determine whether their product is being recalled and obtain suitable alternatives. The WFH is monitoring the situation globally and will inform the community as soon as new information becomes available.

To read the Health Canada drug alert please click here.

To read the UK drug alert please click here.